Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Plasma oncotic pressure is the component of osmotic pressure in blood plasma that is exerted by plasma proteins, especially albumin, which are too large to cross the capillary wall[1][2][3][4]. This pressure is a key determinant for retaining water within the vasculature and opposing the leakage (filtration) of water into the interstitial (tissue) compartment. Failure of this mechanism, as seen in hypoalbuminemia or increased capillary permeability, leads to clinical conditions such as edema or ascites. The process is not attributed to a single target but rather the collective action of several plasma proteins, with albumin being the most significant contributor.
Increase oncotic pressure to draw and retain fluid within the intravascular compartment
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Plasma oncotic pressure maintenance via macromolecule retention.